Launch Readiness, HTA Submission Preparation and Market Entry Sequencing
IGES Italy Pharma Consulting
Service ID:
EP375S3This individualised service supports EIC Transition and EIC Accelerator beneficiaries that are preparing for first commercialisation or expansion into new European markets and definition of a structured and access-oriented market entry pathway. Activities include assessment of launch sequence and country prioritisation, review of pricing and reimbursement pathways, HTA submission readiness assessment, stakeholder and payer mapping, identification of evidence gaps relevant for launch, and refinement of the product value story for market access decision-makers. The goal is to help beneficiaries align commercial, access, and evidence considerations before launch and to define the optimal order and conditions for entry into selected European markets. Expected outcomes include a launch sequence recommendation, a country-level market entry roadmap, a prioritised HTA and reimbursement preparation plan, and a concise set of actions to reduce pre-launch access risk. The service is delivered remotely through tailored expert sessions.
Negotiable (1-2 free initial scoping calls).
Deadlines are decided on each project bases and request. No specific disclaimers. Projects are built based on the technology and customer need.
Are you in doubt if this is the right service for you, or do you want to get more information about the service? Get in touch with the EIC Partner providing this service through this query form!
Is this the service you are looking for? If so, you can apply to the service through EIC ACCESS+! Eligible applicants can also get co-funding through the EIC ACCESS+ initiative. Find out more on the project webiste.
Receive up to €60,000 in grants, covering up to 50% of the costs, to access specialised services from the EIC Service Catalogue. Learn more on the EIC ACCESS+ website.